A researcher at AimedBio, a local biotech company specializing in antibody-drug conjugates technology, looks at a monitor in a lab. The Life Science Fund of Samsung C&T, Samsung Biologics and Samsung Bioepis announced Wednesday that it made an equity investment in the local company. [SAMSUNG BIOLOGICS] Samsung's Life Science Fund made an equity investment in AimedBio, a Korean biotech company specializing in antibody-drug conjugates (ADC), Samsung Biologics said Wednesday. This is the fund's fourth investment, and the first in a domestic company.

https://n.news.naver.com/mnews/article/640/0000043312?sid=101

#naver